Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5180)
All Articles published online
|
Publishing Process of This Article
|
Jun 7, 2013 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu Y, Wei ZW, He YL, Schwarz RE, Smith DD, Xia GK, Zhang CH. Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer. World J Gastroenterol 2013; 19(21): 3309-3315 [PMID: 23745033 DOI: 10.3748/wjg.v19.i21.3309] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i21/3309.htm |
| Number | Citing Articles |
| 1 |
Ji-Xiang Zhang, Zi-Rong Yang, Dan-Dan Wu, Jia Song, Xu-Feng Guo, Jing Wang, Wei-Guo Dong. Suppressive Effect of Sinomenine Combined with 5-Fluorouracil on Colon Carcinoma Cell Growth. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6737 doi: 10.7314/APJCP.2014.15.16.6737
|
| 2 |
Wei-Ming Kang, Qing-Bin Meng, Jian-Chun Yu, Zhi-Qiang Ma, Zhi-Tian Li. Factors associated with early recurrence after curative surgery for gastric cancer. World Journal of Gastroenterology 2015; 21(19): 5934-5940 doi: 10.3748/wjg.v21.i19.5934
|
| 3 |
Zhe-Wei Wei, Jia-Ling Li, Ying Wu, Guang-Kai Xia, Roderich E. Schwarz, Yu-Long He, Chang-Hua Zhang. Impact of Pre-existing Type-2 Diabetes on Patient Outcomes After Radical Resection for Gastric Cancer: A Retrospective Cohort Study. Digestive Diseases and Sciences 2014; 59(5): 1017 doi: 10.1007/s10620-013-2965-6
|
| 4 |
Hongming Fang, Yaping Zhang, Zhibing Wu, Xiaoyan Wang, Hui Wang, Ying Wang, Feng Chai, Yiling Jiang, Zhongqiang Jin, Yu Wan, Lucheng Zhu, Shenglin Ma. Regional hyperthermia combined with chemotherapy in advanced gastric cancer. Open Medicine 2019; 14(1): 85 doi: 10.1515/med-2019-0012
|
| 5 |
Zi-Xian Wang, Xu-Long Yang, Ming-Ming He, Feng Wang, Dong-Sheng Zhang, Yu-Hong Li, Zhi-Wei Zhou, You-Qing Zhan, Rui-Hua Xu. The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy. Medicine 2016; 95(16): e3214 doi: 10.1097/MD.0000000000003214
|
| 6 |
Pengfei Yu, Yian Du, Xiangdong Cheng, Qiming Yu, Ling Huang, Ruizeng Dong. Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer. World Journal of Surgical Oncology 2014; 12(1): 307 doi: 10.1186/1477-7819-12-307
|
| 7 |
Xiangdong Cheng, Yi Lu. A review of capecitabine-based adjuvant therapy for gastric cancer in the Chinese population. Future Oncology 2018; 14(8): 771 doi: 10.2217/fon-2017-0558
|
| 8 |
Lei Chen, Chenghai Zhang, Zhendan Yao, Ming Cui, Jiadi Xing, Hong Yang, Nan Zhang, Maoxing Liu, Kai Xu, Fei Tan, Yuzhe Li, Beihai Jiang, Xiangqian Su. Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08717-4
|